All In MedTech

FDA Clearance Tracker · P850010

HELISTAT(TM) ABSORBABLE COLLAGEN HEMOSTATIC SPONGE

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Nov 8, 1985 (this decision)Source: openFDAMethods & limitations

PMA

Decided

Nov 8, 1985

Approved

Time to decision

261 days

Received Feb 20, 1985. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P850010
Device name
HELISTAT(TM) ABSORBABLE COLLAGEN HEMOSTATIC SPONGE
Applicant location
Plainsboro, NJ
Received
Feb 20, 1985
Decided
Nov 8, 1985
Decision
Approved
Supplements
113 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III
Regulation
21 CFR 878.4490

Every decision under product code LMF

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code LMF. The earliest in FDA's data is N17600, decided Aug 26, 1976.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Integra LifeSciences Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.